UTIAMC2021-10-012021-12-31in-bse-fin:OneOtherRevenueFromOperations01Member UTIAMC2021-10-012021-12-31in-bse-fin:FourOtherRevenueFromOperations01Member UTIAMC2021-10-012021-12-31in-bse-fin:OneOperatingExpenses01Member UTIAMC2021-10-012021-12-31in-bse-fin:FourOperatingExpenses01Member UTIAMC2021-10-012021-12-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member UTIAMC2021-10-012021-12-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares UTIAMC 2021-04-01 2022-03-31 2021-12-29 INR Crores Third quarter false Single segment The Company is in the business of providing asset management services to UTI Mutual Fund and portfolio management & advisory services to clients & providing Point of Presence service to NPS subscriber. The primary segment is identified as asset management services and accordingly there are no separate reportable segments as per Ind AS 108 - Operating Segment. 2021-10-01 2021-12-31 Unaudited Standalone 47800000.00 0.00 31700000.00 0.00 16800000.00 0.00 0.00 2258100000.00 135700000.00 2490100000.00 1300000.00 2491400000.00 0.00 0.00 0.00 864300000.00 25500000.00 87800000.00 21300000.00 0.00 0.00 0.00 282700000.00 1281600000.00 1209800000.00 0.00 1209800000.00 275000000.00 -103400000.00 171600000.00 1038200000.00 0.00 0.00 0.00 0.00 1038200000.00 85600000.00 1123800000.00 1123800000.00 0.00 1268900000.00 10 8.18 8.14 0.00 0.00 8.18 8.14 0.00 0.00 0.00 1. The standalone financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 - Interim Financial Reporting, notified under Section 133 of the Companies Act, 2013 and other accounting principles generally accepted in India. 2. The Company has followed the same accounting policies in the preparation of these financial results as those followed in the annual financial statements for the year ended March 31, 2021. 3. The Nomination and Remuneration Committee of the Board of Directors of the Company at its meeting held on July 28, 2021 had approved grant of 8,61,350 stock options representing 8,61,350 equity shares of Rs. 10 each, at a grant price of Rs. 923.20 per equity share (being the market price as defined in the applicable SEBI Regulations), to the eligible employees under “UTI AMC Employee Stock Option Scheme -2007”. The total charge for share based payment to employees for the quarter and nine months period ended December 31, 2021 is Rs. 6.41 crore and Rs. 15.78 crore, respectively including ESOPs granted on 16 December, 2019 under “UTI AMC Employee Stock Option Scheme -2007”. 4. During the quarter and nine months period ended December 31, 2021, the Company has allotted 54,469 equity shares and 1,01,735 equity shares, respectively of face value Rs. 10 each pursuant to exercise of stock options by certain employees. 5. During the nine months period ended December 31, 2021, the Company has paid a final dividend of Rs. 17 per equity share (Previous Year Rs.7 per share) for the year ended March 31, 2021 as approved by its shareholders at the Annual General Meeting held on July 28, 2021. 6. The Company is in the business of providing asset management services, portfolio management, advisory services and providing Point of Presence service to NPS subscriber. The primary segment is identified as asset management services. As such, the Company's financial results are largely reflective of asset management business, accordingly, there are no separate reportable segments as per Ind AS 108 - Operating Segments. 7. The outbreak of COVID - 19 pandemic has affected several countries across the world, including India, resulting in significant volatility in financial market and significant decrease in global and Indian economy. The Government is undertaking several measures to restrict the spread of virus and provide financial support to some stressed sectors. While the situation had improved significantly and there had been an all-round recovery in economic activity, a new variant of the virus named Omicron recently emerged which has led to fresh concerns. However, the situation will have to be closely monitored till the pandemic is finally put to rest. The extent to which the pandemic will impact the Company’s results will depend on ongoing as well as future developments, which at this juncture are highly uncertain. Management will continue to closely monitor the material changes in the macro-economic factors impacting the operations of the Company. Further, during the quarter ended December 31, 2021, there has been no material change in the controls or processes followed in the preparation of the financial results. 8. The above results for the quarter and nine months period ended December 31, 2021, which have been subjected to a Limited Review by the Statutory Auditors of the Company, have been reviewed by the Audit Committee and subsequently approved by the Board of Directors at its meeting held on January 28, 2022, in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 9. Previous period’s/year’s figures have been regrouped / reclassified wherever necessary, to conform to current period’s presentation. Single segment 2021-04-01 2021-12-31 Unaudited Standalone 128500000.00 200000.00 86400000.00 0.00 291200000.00 0.00 0.00 6709000000.00 757200000.00 7972500000.00 7000000.00 7979500000.00 0.00 0.00 0.00 2614900000.00 69200000.00 257900000.00 59200000.00 0.00 0.00 0.00 864900000.00 3866100000.00 4113400000.00 0.00 4113400000.00 910000000.00 -228700000.00 681300000.00 3432100000.00 0.00 0.00 0.00 0.00 3432100000.00 -29400000.00 3402700000.00 3402700000.00 0.00 1268900000.00 10 27.06 26.95 0.00 0.00 27.06 26.95 0.00 0.00 0.00 Others - net gain/loss on sale of investments 135700000.00 Others - net gain/loss on sale of investments 757200000.00 Other expenses 282700000.00 Other expenses 864900000.00 0.00 0.00 0.00 0.00 85600000.00 -29400000.00